Correlation of angiotensin I-converting enzyme gene insertion/deletion polymorphism with rheumatic heart disease: a
Yulong Tian1, Zhongchun Ge1, Yuliang Xing1
1Department of Cardiology, People's Hospital of Xuyi, Xuyi 211700, Jiangsu, P.R. China.
Insights
This study found no significant link between the ACE I/D gene variant and rheumatic heart disease (RHD) risk. Further research with larger sample sizes is needed to confirm these findings on RHD susceptibility.
Area of Science:
- Cardiovascular Genetics
- Molecular Epidemiology
- Rheumatic Heart Disease Research
Background:
- Rheumatic heart disease (RHD) poses a significant global cardiovascular health burden.
- Previous studies suggest a potential link between the angiotensin I-converting enzyme gene insertion/deletion (ACE I/D) polymorphism and RHD susceptibility, but findings are inconsistent.
Purpose of the Study:
- To conduct a meta-analysis to precisely estimate the association between the ACE I/D variant and RHD risk.
- To investigate potential influences of ethnicity and RHD severity on this relationship.
Main Methods:
- Systematic literature search for case-control studies published between January 2000 and 2016.
- Meta-analysis of nine selected studies, comprising 1333 RHD patients and 1212 healthy controls.
- Calculation of odds ratios (OR) with 95% confidence intervals (CI) to assess the strength of association.
Main Results:
- No statistically significant association was detected between ACE I/D polymorphism and RHD risk across all genetic models (P > 0.05).
- Subgroup analysis by ethnicity, including Asian populations, also revealed no significant relationship.
- No significant differences in ACE I/D polymorphism frequency were observed concerning RHD severity (mitral valve lesion, combined valve lesion) or sex.
Conclusions:
- The ACE I/D polymorphism does not appear to be a significant risk factor for rheumatic heart disease progression based on current evidence.
- The findings highlight the need for larger, well-designed studies to definitively confirm or refute the role of ACE I/D polymorphism in RHD.
Abstract:
Rheumatic heart disease (RHD) is a serious cardiovascular disorder worldwide. Several articles have reported the effect of angiotensin I-converting enzyme gene insertion/deletion (ACE I/D) polymorphism in RHD risk. However, the results still remain inconsistent. The objective of the present study was to assess more precise estimations of the relationship between ACE I/D variant and RHD susceptibility. Relevant case-control studies published between January 2000 and 2016 were searched in the electronic databases. The odds ratio (OR) with its 95% confidence interval (CI) was employed to calculate the strength of the effect. A total of nine articles were retrieved, including 1333 RHD patients and 1212 healthy controls. Overall, our result did not detect a significant association between ACE I/D polymorphism and RHD risk under each genetic model (P > 0.05). Subgroup analysis by ethnicity showed no positive relationship in Asians as well (P > 0.05). With respect to the severity of RHD, our result found that the frequency differences between mitral valve lesion (MVL), combined valve lesion (CVL) and healthy controls were not significantly different. Furthermore, no significant association was found between female, male RHD patients and the controls regarding to the ACE I/D polymorphism. In conclusion, our result indicated that ACE I/D polymorphism might not be a risk factor for RHD progression based on the existing research results. Additional well-designed studies with larger samples are still needed to confirm these findings.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease III: Medical Management
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Rheumatic Heart Disease IV: Nursing Management
Cardiomyopathy IV: Restrictive Cardiomyopathy


